Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0015695 (
fatty liver
)
13,941
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Microbiota has been widely considered to play a critical role in human carcinogenesis. Human papilloma virus, hepatitis B and C virus, and
Helicobacter pylori
are implicated in the pathogenesis of cancer of uterine cervix, liver, and stomach, respectively. However, whether
Porphyromonas gingivalis (P. gingivalis)
, a common Gram negative oral bacteria, is associated with oral carcinogenesis still remains unclear and its underlying mechanism needs to be addressed. Here, we established a combined experimental system of 4NQO-induced oral carcinoma model and chronic periodontitis model and investigated the effects of
P. gingivalis
infection on oral carcinogenesis and fatty acid metabolism during oral carcinogenesis. The data showed that in this animal model,
P. gingivalis
infection induced mice periodontitis, increased the tongue lesion size and multiplicity of each mouse and promoted
oral cancer
development.
P. gingivalis
treatment significantly increased the level of free fatty acids and altered the fatty acid profile in tongue tissues and the serum of mice. And
P. gingivalis
induced the formation of
fatty liver
of the mice. Besides, immunohistochemical analysis and qRT-PCR showed that the expression of fatty-acid synthase and acetyl-CoA carboxylase 1 were increased in the tongue and liver tissues of 4NQO-treated mice infected with
P. gingivalis
. These results showed that
P. gingivalis
promoted oral carcinogenesis and aggravated disturbance of fatty acid metabolism, indicating a close association among
P. gingivalis
, lipid metabolic and oral carcinogenesis.
...
PMID:
Porphyromonas gingivalis
Promotes 4-Nitroquinoline-1-Oxide-Induced Oral Carcinogenesis With an Alteration of Fatty Acid Metabolism. 3023 49